An image showing antibody-drugconjugates

BMS and Eisai agree antibody-drug conjugate commercialisation deal

2021-06-22T09:50:00+01:00By

Companies will jointly develop cancer treatment, with BMS paying up to $3 billion for shared rights

An image showing the REGN-COV drug

Regeneron’s Covid-19 antibodies help those who can’t make their own

2021-06-18T13:42:00+01:00By

Regn-Cov2 reduces deaths and shortens hospitalisation for these patients, even when given at late stages of infection

An image showing a patient's hand during an aducanumab clinical trial

Alzheimer’s antibody gets surprise US approval

2021-06-16T14:32:00+01:00By

Good news for industry and future drug approvals, but physicians doubt it will be effective for most patients

An image showing the Wah Yan Hong Chemical Factory

Eight dead in apparent methyl formate leak at Chinese chemical plant

2021-06-16T08:30:00+01:00

Three others injured at facility in Guizhou after accidental release during unloading

An image showing two men pointing at the aftermath of a chemical fire

Deadly fire in Indian chemical factory

2021-06-15T10:01:00+01:00

Blaze killed 18 workers, mainly women, who were trapped inside SVS Aqua Technologies plant

An image showing a view of Deer Park Shell refinery outside Houston, Texas

Shell to sell US refinery stake to Mexican state-owned petroleum company

By

Pemex will take full control of Deer Park refinery, as Mexico’s president moves to gain energy independence

An image showing a stalemate game

Striving to bolster the antibiotic pipeline before it becomes the next crisis

By Katrina Megget

It’s been almost 10 years since the world was warned of a post-antibiotic apocalypse. Katrina Megget takes a look at the initiatives trying to support antimicrobial R&D

An image showing an Enbrel injection

US supreme court ends Sandoz–Amgen biosimilar dispute

By

Sandoz’s copy of arthritis drug Enbrel won’t be available in the US until 2029, 30 years after it was first marketed

An image showing a woman with barrels

What might UK Reach look like?

By Vanessa Zainzinger

As the UK’s legal system finds its feet post-Brexit, stakeholders have mixed feelings about the changes it could bring